drugset / Trial / NCT00852865

Lactobacillus Farciminis and Hyperalgesia

NCT00852865 ↗

Phase 1 Completed 48 enrolled Lallemand SAS
RandomizedParallel-groupDouble-blindTreatment

Summary

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Timeline

Start
2009-02
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus farciminis Other / unclassified 4e+09 cells —

Indications

No indication recorded.